Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Marguerite, Tyran"'
Autor:
Etienne Gouton, Marine Gilabert, Simon Launay, Elika Loir, Marguerite Tyran, Philippe Rochigneux, Olivier Turrini, Jonathan Garnier, Emmanuel Mitry, Brice Chanez
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
BackgroundBrain metastases (BM) are rare in pancreatic ductal adenocarcinoma (PDAC) and little data exists concerning these patients and their outcomes.AimWe aimed to analyze the management, practices, and outcomes of patients presenting BM from PDAC
Externí odkaz:
https://doaj.org/article/9615042721c049e888c9a7331ba05b22
Autor:
Agnès Tallet, Jean-Marie Boher, Marguerite Tyran, Hugues Mailleux, Gilles Piana, Mohamed Benkreira, Pierre Fau, Naji Salem, Laurence Gonzague, Claire Petit, Julien Darréon
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveTo determine the MRI-Linac added value over conventional image-guided radiation therapy (IGRT) in liver tumors Stereotactic ablative radiation therapy (SABR).Materials and methodsWe retrospectively compared the Planning Target Volumes (PTVs)
Externí odkaz:
https://doaj.org/article/6e379b791eb64f8b87d895bb06c7deae
Autor:
Philippe Rochigneux, Marguerite Tyran, Aurélie Autret, Leonor Lopez Almeida, Jérôme Guiramand, Marjorie Ferre, Brice Chanez, Emmanuel Mitry, Jean Philippe Ratone, Marc Giovannini, Agnès Tallet, Laurence Moureau-Zabotto, Fabrice Caillol
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
PurposeThis prospective monocentric phase II study (FIDUCOR-study, NCT02526134) aimed to assess the impact of fiducial markers (FMs) implantation on conformal chemo-radiation therapy (CRT) planning in oesophageal carcinoma (EC) patients.Methods/mater
Externí odkaz:
https://doaj.org/article/951cc4f693cd4537ad880af72c4087ab
Autor:
Leonel Varela Cagetti, Laurence Moureau-Zabotto, Christophe Zemmour, Marjorie Ferré, Marc Giovaninni, Flora Poizat, Bernard Lelong, Cecile De Chaisemartin, Emmanuel Mitry, Marguerite Tyran, Amira Zioueche-Mottet, Naji Salem, Agnès Tallet
Publikováno v:
Brachytherapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a9475279a7732a818a3f4e460697cc1
https://doi.org/10.1016/j.brachy.2023.03.004
https://doi.org/10.1016/j.brachy.2023.03.004
Autor:
Leonel Varela Cagetti, Laurence Gonzague, Christophe Zemmour, Cyrus Chargari, Agnès Tallet, Marjorie Ferre, Pierre Annede, Pierre Fau, Marguerite Tyran
Publikováno v:
Brachytherapy. 20:748-754
Only scarce data are available on the possibility to reduce rectal dose by controlling rectum filling before HDR (high dose rate) IGABT (image-guided adaptive brachytherapy) in LACC (locally advanced cervical carcinoma) patients. We compared dosimetr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e292a03b6c287f337e86c571f2475f65
https://doi.org/10.1016/j.brachy.2021.03.008
https://doi.org/10.1016/j.brachy.2021.03.008
Autor:
Suzanne Brachet, Hélène Meillat, Brice Chanez, Jean-Philippe Ratone, Serge Brunelle, Marguerite Tyran, Flora Poizat, Cécile de Chaisemartin, Bernard Lelong
Publikováno v:
Diseases of the colon and rectum. 65(12)
Neoadjuvant chemoradiotherapy followed by radical surgery is the standard curative treatment for mid- to low-rectal cancer. However, the combination of these treatments may affect patients' GI and genitourinary functions and their quality of life. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2d3bce3193592bd7d001b4719565a39
https://pubmed.ncbi.nlm.nih.gov/35913830
https://pubmed.ncbi.nlm.nih.gov/35913830
Publikováno v:
Bulletin du Cancer. 108:49-54
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d5cc9520ac7653e29f0639ea37de78d
https://doi.org/10.1016/j.bulcan.2020.10.002
https://doi.org/10.1016/j.bulcan.2020.10.002
Autor:
Fabienne Portales, Marc Ychou, Emmanuelle Samalin, Eric Assenat, Stephane Obled, Marguerite Tyran, Emmanuel Mitry, Magali Rouffiac, François Ghiringhelli, Jean-Baptiste Bachet, Jean-Marc Simon, Mark De Ridder, Catherine Fiess, Aurore Moussion, Stephanie Delaine, Florin Grigorescu, Sophie Gourgou, Olivier Riou
Publikováno v:
Journal of Clinical Oncology. 40:TPS4191-TPS4191
TPS4191 Background: LAPC represents a major challenge with no standardized chemotherapy (CT) and radiotherapy (RT) treatment. Phase 2 studies (LAPACT/NEOLAP) indicated efficacy of FFX and GA, although addition of conventionally fractionated RT remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da51fd88debbcc56264b28369584f634
https://doi.org/10.1200/jco.2022.40.16_suppl.tps4191
https://doi.org/10.1200/jco.2022.40.16_suppl.tps4191
Publikováno v:
Case Reports in Hematology, Vol 2014 (2014)
Localized Nodular Lymphocyte Predominant Hodgkin Lymphoma is a rare disease with an overall good prognosis but frequent late relapses. Due to it’s rarity there is no standard therapeutic approach and pathological diagnosis may be hard. In this pape
Externí odkaz:
https://doaj.org/article/c656df257bbd4152a52c1836bb784c3e
Autor:
Marguerite, Tyran, Pierre, Fau, Hugues, Mailleux, Pierre, Eustache, Mohamed, Benkreira, Naji, Salem, Véronique, Favrel, Laurence, Gonzague, Laurence, Moureau-Zabotto, Leonel, Varela, Pierre, Annede, Agnes, Tallet
Publikováno v:
Bulletin du cancer. 108(11)
Several centers have recently been equipped with MRI-guided radiotherapy systems, including the Paoli-Calmettes Institute which was the first French center to start this activity. We report in this article our early experience.Data related to patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::21bae555ad0d89eddf69eff00192a053
https://pubmed.ncbi.nlm.nih.gov/34625203
https://pubmed.ncbi.nlm.nih.gov/34625203